Editorial
Nature Medicine 13, 761 (2007)
doi:10.1038/nm0707-761
A power surge before a short circuit
Abstract
The FDA needs more power to monitor the safety of drugs in the market, but it also needs to show that it can handle the additional responsibilities.
